TY - JOUR
T1 - Functional domains essential for Gs activity in prostaglandin EP2 and EP3 receptors
AU - Sugimoto, Yukihiko
AU - Nakato, Toshiyuki
AU - Kita, Ayumi
AU - Hatae, Noriyuki
AU - Tabata, Hiroyuki
AU - Tanaka, Satoshi
AU - Ichikawa, Atsushi
N1 - Funding Information:
We thank Ms. S. Terai for secretarial assistance. This work was supported in part by the grants from the Sankyo Foundation of Life Science, the Takeda Science Foundation, the Mochida Memorial Foundation for Medical and Pharmaceutical Research, and grants-in-aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology of Japan.
PY - 2003/12/5
Y1 - 2003/12/5
N2 - The interaction of cell surface hormone receptors with heterotrimeric G proteins is crucial for hormonal actions. The domains of the receptor, which interact with and activate G protein, have been extensively studied. However, precise molecular mechanisms underlying regulation of the receptor-induced G protein activation are still poorly understood. Prostaglandin E2 (PGE2) receptors comprise of four subtypes, EP1, EP2, EP3 and EP4. Among them, EP2 and EP4 couple to Gs and EP3 to Gi. To assess the functional domains essential for Gs activation in prostanoid receptors, EP2, EP3β and each intracellular loop- (IC-) interchanged EP2/EP3 chimeras were tested for agonist binding and functional responses. In EP2 receptor, substitution of IC1 or IC3 resulted in loss of binding activity, while substitution of IC2, N- (IC2N) or C-terminal half region of IC2 (IC2C) had no effects on the binding activity. Wild-type EP2 and IC2C-substituted EP2 showed agonist-induced Gs activity, but IC2- and IC2N-substituted EP2 failed to elicit Gs activity upon agonist stimulation. On the other hand, in EP3 receptor substitution of IC1 resulted in loss of PGE2 binding, while substitution of IC2, IC3, IC2N or IC2C had no effects on binding activity. Wild-type EP3β, IC3- or IC2C-substituted EP3 failed to show Gs activity upon agonist stimulation, but IC2- or IC2N-substituted EP3 chimera showed agonist-dependent Gs activity. These results indicated that the second intracellular loop of the EP2 plays an essential role in activation of Gs.
AB - The interaction of cell surface hormone receptors with heterotrimeric G proteins is crucial for hormonal actions. The domains of the receptor, which interact with and activate G protein, have been extensively studied. However, precise molecular mechanisms underlying regulation of the receptor-induced G protein activation are still poorly understood. Prostaglandin E2 (PGE2) receptors comprise of four subtypes, EP1, EP2, EP3 and EP4. Among them, EP2 and EP4 couple to Gs and EP3 to Gi. To assess the functional domains essential for Gs activation in prostanoid receptors, EP2, EP3β and each intracellular loop- (IC-) interchanged EP2/EP3 chimeras were tested for agonist binding and functional responses. In EP2 receptor, substitution of IC1 or IC3 resulted in loss of binding activity, while substitution of IC2, N- (IC2N) or C-terminal half region of IC2 (IC2C) had no effects on the binding activity. Wild-type EP2 and IC2C-substituted EP2 showed agonist-induced Gs activity, but IC2- and IC2N-substituted EP2 failed to elicit Gs activity upon agonist stimulation. On the other hand, in EP3 receptor substitution of IC1 resulted in loss of PGE2 binding, while substitution of IC2, IC3, IC2N or IC2C had no effects on binding activity. Wild-type EP3β, IC3- or IC2C-substituted EP3 failed to show Gs activity upon agonist stimulation, but IC2- or IC2N-substituted EP3 chimera showed agonist-dependent Gs activity. These results indicated that the second intracellular loop of the EP2 plays an essential role in activation of Gs.
KW - G protein
KW - PGE
KW - Prostaglandin E subtypes
UR - http://www.scopus.com/inward/record.url?scp=0242352663&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0242352663&partnerID=8YFLogxK
U2 - 10.1016/j.lfs.2003.09.002
DO - 10.1016/j.lfs.2003.09.002
M3 - Article
C2 - 14607240
AN - SCOPUS:0242352663
SN - 0024-3205
VL - 74
SP - 135
EP - 141
JO - Life Sciences
JF - Life Sciences
IS - 2-3
ER -